OrganaBio to exhibit at 2022 ASH Annual Meeting and Exposition in New Orleans, LA. Visit booth 2143 to learn more about our unique, flexible model which combines proprietary and scalable tissue sourcing with advanced processing and characterization of perinatal and adult peripheral blood.
NEW ORLEANS--(BUSINESS WIRE)-- Attending ASH22 American Society of Hematology between December 10-12?
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221121005854/en/
OrganaBio to exhibit at 2022 ASH Annual Meeting and Exposition in New Orleans, LA. Visit booth 2143 to learn more about our unique, flexible model which combines proprietary and scalable tissue sourcing with advanced processing and characterization of perinatal and adult peripheral blood (including umbilical cord blood and leukopaks). (Graphic: Business Wire)
Our unique, flexible model combines proprietary and scalable tissue sourcing with advanced processing and characterization of perinatal and adult peripheral blood (including umbilical cord blood and leukopaks). OrganaBio can tailor our products and services to your evolving needs, such as rapidly manufacturing a variety of isolated cells such as CD34+ HSCs, T, B & NK Cells, and macrophages from tissues for pre-clinical research use as well as in the manufacturing of clinical-grade cell therapies. Visit us at booth 2143 or schedule a time to meet with our VP of Corporate Development, Dr. Priya Baraniak: https://meetings.hubspot.com/priya21/meet-with-dr-priya-baraniak
View source version on businesswire.com: https://www.businesswire.com/news/home/20221121005854/en/
Contacts
Dr. Priya Baraniak
Vice President of Corporate Development
priya@organabio.com
Source: OrganaBio
OrganaBio to exhibit at 2022 ASH Annual Meeting and Exposition in New Orleans, LA. Visit booth 2143 to learn more about our unique, flexible model which combines proprietary and scalable tissue sourcing with advanced processing and characterization of perinatal and adult peripheral blood (including umbilical cord blood and leukopaks). (Graphic: Business Wire)
View this news release and multimedia online at:
http://www.businesswire.com/news/home/20221121005854/en
